drugset / Trial / NCT04052932
A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will assess the serum uric acid lowering effects and safety of SHR4640 compared to placebo and Allopurinol in patients with gout
Timeline
- Start
- 2019-07-16
- Primary completion
- 2021-07-14
- Completion
- 2021-07-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Allopurinol | Small molecule | 300 mg | Oral |
| Subject | SHR4640 | Small molecule | — | Oral |